You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -42.3% | -22.1% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -72.9 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 35.2 | 27.4 |
| Price / Book value | 27.8 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 21.0% | 9.5% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | 12.27 | -3.35 | $-0.11 | -15.4 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | 13.98 | -9.92 | $-0.20 | -16.3 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | 16.67 | -8.87 | $-0.17 | -14.2 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 21.62 | -12.89 | $-0.23 | -7.2 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | 26.17 | -11.82 | $-0.17 | -42.4 | 0.0 | n/a | n/a | 0.0% |
| MaxCyte reports good performance despite Covid challenges Sharecast News | 20 Apr |
|---|---|
| MaxCyte raises £40m from new and existing investors Sharecast News | 04 Feb |
| MaxCyte revenue growth expected to accelerate faster than anticipated Sharecast News | 20 Jan |
| Full Year Results | 20-Apr-21 07:00 |
|---|---|
| Notice of Full Year Results | 15-Apr-21 07:00 |
| Total Voting Rights | 01-Apr-21 07:00 |
| Holding(s) in Company | 11-Mar-21 15:02 |
| Total Voting Rights | 03-Mar-21 07:01 |